483
Kailash K. Jindal, MD, PIKailash K. Jindal, MD, PI – FDA 483, Jun 27, 2014
Record Details
An FDA inspection of Kailash K. Jindal, MD, PI, a clinical investigator in Edmonton, Alberta, revealed significant deviations from the investigational plan. Observations included failure to withhold study drug when subjects were prescribed antibiotics/antifungals and enrollment of a subject with an active bacterial infection, both contrary to protocol requirements. These issues indicate a lack of adherence to study protocols during the clinical investigation.
View Company Profile
ID · 8394457a-875e-4fcf-885e-b670ab75804b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.